Zificsak, Craig A.; Gingrich, Diane E.; Breslin, Henry J.; Dunn, Derek D.; Milkiewicz, Karen L.; Theroff, Jay P.; Thieu, Tho V.; Underiner, Ted L.; Weinberg, Linda R.; Aimone, Lisa D.; Albom, Mark S.; Mason, Jennifer L.; Saville, Lisa; Husten, Jean; Angeles, Thelma S.; Finn, James P.; Jan, Mahfuza; O’Kane, Teresa M.; Dobrzanski, Pawel; Dorsey, Bruce D. published the artcile< Optimization of a novel kinase inhibitor scaffold for the dual inhibition of JAK2 and FAK kinases>, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate, the main research area is anilino pyrrolo triazine dual inhibitor JAK2 FAK kinase cancer.
The elaboration of a novel scaffold for the inhibition of JAK2 and FAK kinases was targeted in order to provide a dual inhibitor that could target divergent pathways for tumor cell progression.
Bioorganic & Medicinal Chemistry Letters published new progress about Activin receptor ALK4 Role: BSU (Biological Study, Unclassified), BIOL (Biological Study). 112-63-0 belongs to class esters-buliding-blocks, and the molecular formula is C19H34O2, Name: (9Z,12Z)-Methyl octadeca-9,12-dienoate.
Referemce:
Ester – Wikipedia,
Ester – an overview | ScienceDirect Topics